An analysis of six tests that are used to measure platelet function and help gauge the effectiveness of antiplatelet drugs for patients undergoing a cardiac procedure such as a coronary stent ...

Among patients with acute coronary syndromes undergoing a procedure such as angioplasty, those who received platelet function tests before receiving antithrombotic therapy to determine appropriate ...

Platelet function testing in patients on clopidogrel therapy shows only a weak link between reactivity and stent thrombosis. This drawback could prove to be a serious obstacle to the adoption of such ...

Using platelet function testing to determine the optimal time for coronary artery bypass graft (CABG) surgery can shorten the waiting time before bypass in clopidogrel-treated patients without ...

The RECLOSE 2–ACS (Responsiveness to Clopidogrel and Stent Thrombosis 2–ACS) trial from Italy provides new information about platelet reactivity but doesn't answer any of the key questions about the ...

SAN FRANCISCO, CA — Physicians are far more likely to order a VerifyNow (Accumetrics) platelet-function test for their patients with acute MI if the point-of-care assay is offered to them for free, ...

November 15, 2009 (Orlando, Florida) — Results for the first head-to-head comparison of different platelet-function tests suggests that a handful of platelet reactivity assays--used to test the ...

Forbes contributors publish independent expert analyses and insights. I'm a medical journalist covering cardiology news. The use of platelet-function tests to monitor and guide antiplatelet therapy in ...

Is a medical journal ad for platelet-inhibition testing backed up by evidence that treatment guided by such testing can reduce the risk of clot formation? No, writes Yale cardiologist Harlan Krumholz.

The global platelet function test market is poised for robust growth over the next decade, fueled by innovations in diagnostic technologies and increasing demand for personalized, preventive ...

The global platelet function test market is projected to be valued at USD 1.38 billion in 2025 and is expected to reach USD 2.61 billion by 2035, registering a CAGR of 6.3% during the forecast period.

This release is available in Chinese. An analysis of six tests that are used to measure platelet function and help gauge the effectiveness of antiplatelet drugs for patients undergoing a cardiac ...